---
title: "ETEK: Net profit for the year 2024 is 126 million yuan, a year-on-year decrease of 37.06%"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/229930493.md"
description: "According to the Zhitong Finance APP, ETEK released its 2024 annual performance report. During the reporting period, the company achieved operating revenue of 787 million yuan, a year-on-year decrease of 11.19%; net profit attributable to the parent company's owners was 126 million yuan, a year-on-year decrease of 37.06%; net profit attributable to the parent company's owners after deducting non-recurring gains and losses was 106 million yuan, a year-on-year decrease of 40.54%; basic earnings per share were 0.94 yuan/share"
datetime: "2025-02-27T14:10:05.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/229930493.md)
  - [en](https://longbridge.com/en/news/229930493.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/229930493.md)
---

# ETEK: Net profit for the year 2024 is 126 million yuan, a year-on-year decrease of 37.06%

According to the Zhitong Finance APP, ETEK (688601.SH) released its performance preliminary report for the year 2024. During the reporting period, the company achieved operating revenue of 787 million yuan, a year-on-year decrease of 11.19%; the net profit attributable to the parent company's owners was 126 million yuan, a year-on-year decrease of 37.06%; the net profit attributable to the parent company's owners after deducting non-recurring gains and losses was 106 million yuan, a year-on-year decrease of 40.54%; basic earnings per share were 0.94 yuan/share

### Related Stocks

- [688601.CN](https://longbridge.com/en/quote/688601.CN.md)

## Related News & Research

- [Flow Pharma U.S. Patent Application Allowed for Issuance Covering Broad-Spectrum Ebola Therapy](https://longbridge.com/en/news/287076761.md)
- [HSA warns public against consuming herbal remedy containing potent steroid](https://longbridge.com/en/news/287022845.md)
- [Xiaomi EV reportedly taps new battery suppliers for second brand to target EREV market](https://longbridge.com/en/news/286843996.md)
- [Pop star Wang Leehom swaps Denza endorsement fee for BYD stock](https://longbridge.com/en/news/286844734.md)
- [20:00 ETAccro Bioscience Announces $50 Million Series C Financing Led by OrbiMed to Advance Clinical Pipeline for Immune Mediated Diseases](https://longbridge.com/en/news/286830151.md)